摘要
目的阐述我国药品安全责任体系建设现状及存在的问题,为加强和完善新体制下的药品安全责任体系建设提供参考。方法以鞍山市药品安全责任体系建设为依据,通过文献、调研方法,提出相应的建议。结果与结论为适应监管体制的变化,应采取相应措施,进一步加强药品安全责任体系建设。
Objective Elaborated present situation and existing problems of drug safety responsibility system in China,to provide reference for strengthening and improving drug safety responsibility in new regulatory system.Methods Based on drug safety responsibility system in Anshan,provide views and suggestions by researching literature.Results and Conclusion In order to adapt to the changes of regulatory system,the corresponding measures should be taken to further strengthen drug safety responsibility system.
出处
《中国药事》
CAS
2012年第2期164-165,共2页
Chinese Pharmaceutical Affairs
关键词
药品安全
责任体系
监管部门
drug safety
responsibility system
regulatory authorities